← all drugs
Guanfacine Hydrochloride Tablet, Extended Release
being discontinued · Psychiatry · Snapshot: 2026-10-09
- Manufacturers listed
- Actavis Pharma, Inc.
- Machine-readable
- JSON for this drug
Presentations (4)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Guanfacine Hydrochloride, Tablet, Extended Release, 4 mg (NDC 0228-2855-11) | Actavis Pharma, Inc. | unknown | 11/13/2025 |
| Guanfacine Hydrochloride, Tablet, Extended Release, 2 mg (NDC 0228-2851-11) | Actavis Pharma, Inc. | unknown | 11/13/2025 |
| Guanfacine Hydrochloride, Tablet, Extended Release, 3 mg (NDC 0228-2853-11) | Actavis Pharma, Inc. | unknown | 11/13/2025 |
| Guanfacine Hydrochloride, Tablet, Extended Release, 1 mg (NDC 0228-2850-11) | Actavis Pharma, Inc. | unknown | 11/13/2025 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive). No change to its FDA listing has been observed since.
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.